FDA Approves New Treatment for Postpartum Depression

Postpartum depression is overwhelming depression and the inability to care for yourself and your newborn—about 1 in 7 women will suffer from postpartum depression after giving birth. Progesterone is the most common hormone in pregnancy, and the dramatic drop in progesterone after giving birth may have a role in depression postpartum. OB/GYN Dr. Kirtly Parker Jones talks about the pros and cons of brexanolone, a newly FDA-approved synthetic version of the allopregnanolone steroid, meant to treat postpartum depression.